Nasalide Articles
JOUVEINAL PRODUCTS EFFECT ON W-L PIPELINE
8 February 1993
EURO OSTEOPOROSIS MARKET TO BOOM?
14 December 1992
ANALYST'S ESTIMATES OF US THIRD QTR EARNINGS
12 October 1992
NASAL ASPIRIN
25 May 1992
SMALLER US COMPANIES POST GOOD RESULTS
18 May 1992
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
